Joel Linden, PhD

Joel Linden, PhD

University of Virginia

H-index: 103

North America-United States

About Joel Linden, PhD

Joel Linden, PhD, With an exceptional h-index of 103 and a recent h-index of 43 (since 2020), a distinguished researcher at University of Virginia, specializes in the field of adenosine, cancer, sickle cell anemia, cytokine storm.

His recent articles reflect a diverse array of research interests and contributions to the field:

G protein beta4 as a structural determinant of enhanced nucleotide exchange in the A2A adenosine receptor Gs complex

Unlocking antitumor immunity with adenosine receptor blockers

Regadenoson for the treatment of COVID-19: A five case clinical series and mouse studies

Improved survival of SARS COV-2-infected K18-hACE2 mice treated with adenosine A2AR agonist

Isolation and storage of PBMCs from human peripheral blood samples

Adenosine receptors in GtoPdb v. 2023.1

Adenosine a2a agonists for the treatment of cytokine storm syndrome

Regadenoson reduces soluble receptor for advanced glycation end-products in lung recipients

Joel Linden, PhD Information

University

Position

School of Medicine

Citations(all)

42485

Citations(since 2020)

8823

Cited By

36969

hIndex(all)

103

hIndex(since 2020)

43

i10Index(all)

363

i10Index(since 2020)

140

Email

University Profile Page

University of Virginia

Google Scholar

View Google Scholar Profile

Joel Linden, PhD Skills & Research Interests

adenosine

cancer

sickle cell anemia

cytokine storm

Top articles of Joel Linden, PhD

Title

Journal

Author(s)

Publication Date

G protein beta4 as a structural determinant of enhanced nucleotide exchange in the A2A adenosine receptor Gs complex

Mark Yeager

William McIntire

Michael Purdy

Susan Leonhardt

Iga Kucharska

...

2024/1/23

Unlocking antitumor immunity with adenosine receptor blockers

Victoria A Remley

Joel Linden

Todd W Bauer

Julien Dimastromatteo

2023

Regadenoson for the treatment of COVID-19: A five case clinical series and mouse studies

PLoS One

Joseph Rabin

Yunge Zhao

Ezzat Mostafa

Manal Al-Suqi

Emily Fleischmann

...

2023/8/11

Improved survival of SARS COV-2-infected K18-hACE2 mice treated with adenosine A2AR agonist

Heliyon

Barbara J Mann

Preeti Chhabra

Mingyang Ma

Savannah G Brovero

Riley T Hannan

...

2023/8/1

Isolation and storage of PBMCs from human peripheral blood samples

Yunge Zhao

Joseph Rabin

Joel Linden

Christine L Lau

2023/6/8

Adenosine receptors in GtoPdb v. 2023.1

IUPHAR/BPS Guide to Pharmacology CITE

Bertil B Fredholm

Bruno G Frenguelli

Rebecca Hills

Adriaan P IJzerman

Kenneth A Jacobson

...

2023/4/26

Adenosine a2a agonists for the treatment of cytokine storm syndrome

2023/4/20

Regadenoson reduces soluble receptor for advanced glycation end-products in lung recipients

The Annals of Thoracic Surgery

Yunge Zhao

Urmil Dhru

Emily Fleischmann

Ezzat Mostafa

Manal Al-Suqi

...

2023/12/1

Developmentally distinct CD4+ Treg lineages shape the CD8+ T cell response to acute Listeria infection

Proceedings of the National Academy of Sciences

Joseph S Dolina

Joey Lee

Eugene L Moore

Jennifer L Hope

Donald T Gracias

...

2022/3/8

Adenosine A2A Receptor (A2AR) agonists improve survival in K28-hACE2 mice following SARS CoV-2 infection

bioRxiv

Barbara J Mann

Preeti Chhabra

Mingyang Ma

Savannah G Brovero

Marieke K Jones

...

2022/2/26

P16. 26: Adenosine A2A Receptor (A2AR) Agonists Improve Survival in K28-hACE2 Mice and Syrian Hamsters Following SARS CoV-2 Infection

Transplantation

Preeti Chhabra

Barbara Mann

Mingyang Ma

Sanford Feldman

Joel Linden

...

2022/9/1

Adenosine A2A Receptor (A2AR) Agonist Apadenoson Promotes Survival in K28-hACE2 Mice and Syrian Hamsters Infected with Sars-CoV-2

American Journal of Transplantation

P Chhabra

B Mann

M Ma

S Feldman

J Linden

...

2022

Feeding desensitizes A1 adenosine receptors in adipose through FOXO1-mediated transcriptional regulation

Molecular Metabolism

Mitchell E Granade

Stefan R Hargett

Daniel S Lank

Michael C Lemke

Melissa A Luse

...

2022/9/1

Kinetic profiling and functional characterization of 8-phenylxanthine derivatives as A2B adenosine receptor antagonists

Biochemical pharmacology

Anna Vlachodimou

Henk de Vries

Milena Pasoli

Miranda Goudswaard

Soon-Ai Kim

...

2022/6/1

Regadenoson is safe and reduces systemic inflammation post lung transplantation

The Journal of Heart and Lung Transplantation

Yunge Zhao

Joseph Rabin

Ezzat Mostafa

Emily Fleischmann

Manal Al-Suqi

...

2022/4/1

Adenosine receptors in GtoPdb v. 2021.2

IUPHAR/BPS Guide to Pharmacology CITE

Bertil B Fredholm

Bruno G Frenguelli

Rebecca Hills

Adriaan P IJzerman

Kenneth A Jacobson

...

2021/6/25

Targeting adenosine with adenosine deaminase 2 to inhibit growth of solid tumors

Cancer Research

Lin Wang

Luz M Londono

Jessica Cowell

Ozge Saatci

Mertkaya Aras

...

2021/6/15

Clearance of apoptotic cells by lung alveolar macrophages prevents development of house dust mite-induced asthmatic lung inflammation

Journal of Allergy and Clinical Immunology

Haruka Miki

Hong Pei

Donald Tom Gracias

Joel Linden

Michael Croft

2021/3/1

Search for long-lived particles produced in association with a Z boson in proton-proton collisions at = 13 TeV

arXiv preprint arXiv:2110.13218

CMS collaboration

2021/10/25

Sepsis expands a CD39+ plasmablast population that promotes immunosuppression via adenosine-mediated inhibition of macrophage antimicrobial activity

Immunity

Daniele Carvalho Nascimento

Paula Ramos Viacava

Raphael Gomes Ferreira

Marina Alves Damaceno

Annie Rocío Piñeros

...

2021/9/14

See List of Professors in Joel Linden, PhD University(University of Virginia)

Co-Authors

H-index: 164
Donna Neuberg

Donna Neuberg

Harvard University

H-index: 121
Bertil Fredholm

Bertil Fredholm

Karolinska Institutet

H-index: 108
Simon C. Robson

Simon C. Robson

Harvard University

H-index: 87
Christa E. Müller

Christa E. Müller

Rheinische Friedrich-Wilhelms-Universität Bonn

H-index: 60
Peter B. Ernst

Peter B. Ernst

University of California, San Diego

H-index: 56
Victor E. Laubach, PhD

Victor E. Laubach, PhD

University of Virginia

academic-engine